Mindmed announces collaboration with forian to advance development of personalized psychiatry for anxiety disorders

New york, aug. 24, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, has agreed to work with forian inc. (nasdaq: fora), a leading provider of evidence-based support for more comprehensive clinical and commercial decision-making. mindmed and forian will collaborate to develop best practices for using real-world evidence ("rwe") information to help improve the health and lives of psychiatric patients.
MNMD Ratings Summary
MNMD Quant Ranking